Literature DB >> 7959736

Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.

S Yamanaka1, O N Johnson, F Norflus, D J Boles, R L Proia.   

Abstract

Two genes, HEXA and HEXB, encode the alpha- and beta-subunits, respectively, of human beta-hexosaminidase. In the mouse, the corresponding genes are termed Hexa and Hexb. The subunits dimerize to yield three isozymes, beta-hexosaminidase A (alpha beta), B (beta beta), and S (alpha alpha), that have the capacity to degrade a variety of substrates containing beta-linked N-acetylglucosamine and N-acetylgalactosamine residues. Mutations in the HEXA or HEXB gene resulting in a beta-hexosaminidase deficiency cause Tay-Sachs or Sandhoff disease, respectively. As a prelude to the creation of mouse models of these lysosomal storage diseases, we have characterized the molecular biology of the mouse beta-hexosaminidase system. Protein sequences derived from the cloned Hexa and Hexb cDNAs were 55% identical to each other and were also very similar to the cognate human sequences: 84% sequence identity with human HEXA and 75% with HEXB. The mouse hexosaminidase subunits, when expressed in HeLa cells from the cDNAs, displayed specificity toward synthetic substrates similar to the human subunits. The Hexa and Hexb genes were 25 and 22 kb in length, respectively. Each gene was divided into 14 exons, with the positions of introns precisely matching those of the corresponding human genes. The 5' flanking regions of the mouse genes demonstrated promoter activity as ascertained by their ability to drive chloramphenicol acetyltransferase gene expression in transfected NIH 3T3 cells. The sequences of these regulatory regions were G+C-rich in the 200 bp upstream of the respective initiator ATGs. Several putative promoter elements were present, including Sp1, AP2, CAAT, and TATA motifs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959736     DOI: 10.1006/geno.1994.1318

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

1.  Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.

Authors:  Danielle te Vruchte; Aruna Jeans; Frances M Platt; Daniel John Sillence
Journal:  J Inherit Metab Dis       Date:  2010-05-11       Impact factor: 4.982

2.  Firing up the nature/nurture controversy: bioethics and genetic determinism.

Authors:  I de Melo-Martín
Journal:  J Med Ethics       Date:  2005-09       Impact factor: 2.903

3.  Molecular and functional analysis of the HEXB gene in Italian patients affected with Sandhoff disease: identification of six novel alleles.

Authors:  Stefania Zampieri; Mirella Filocamo; Emanuele Buratti; Marina Stroppiano; Kristian Vlahovicek; Natalia Rosso; Eleonora Bignulin; Stefano Regis; Franco Carnevale; Bruno Bembi; Andrea Dardis
Journal:  Neurogenetics       Date:  2008-08-29       Impact factor: 2.660

4.  Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.

Authors:  M G Ribeiro; T Sonin; R A Pinto; A Fontes; H Ribeiro; E Pinto; M M Palmeira; M C Sá Miranda
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

5.  Molecular cloning and functional characterization of beta-N-acetylglucosaminidase genes from Sf9 cells.

Authors:  Jared J Aumiller; Jason R Hollister; Donald L Jarvis
Journal:  Protein Expr Purif       Date:  2005-12-27       Impact factor: 1.650

6.  Early changes in the apparent diffusion coefficient (ADC) in a mouse model of Sandhoff's disease occur prior to disease symptoms and behavioral deficits.

Authors:  Lingyun Hu; Yingying Sun; Laura E Villasana; Richard Paylor; Eric Klann; Robia G Pautler
Journal:  Magn Reson Med       Date:  2009-11       Impact factor: 4.668

7.  Thymic alterations in GM2 gangliosidoses model mice.

Authors:  Seiichi Kanzaki; Akira Yamaguchi; Kayoko Yamaguchi; Yoshitsugu Kojima; Kyoko Suzuki; Noriko Koumitsu; Yoji Nagashima; Kiyotaka Nagahama; Michiko Ehara; Yoshio Hirayasu; Akihide Ryo; Ichiro Aoki; Shoji Yamanaka
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

8.  Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses.

Authors:  Akira Yamaguchi; Kayoko Katsuyama; Kiyotaka Nagahama; Toshiyuki Takai; Ichiro Aoki; Shoji Yamanaka
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

9.  Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease.

Authors:  S Yamanaka; M D Johnson; A Grinberg; H Westphal; J N Crawley; M Taniike; K Suzuki; R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

10.  TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.

Authors:  Meredith K Loth; Judy Choi; Jennifer L McGlothan; Mikhail V Pletnikov; Martin G Pomper; Tomás R Guilarte
Journal:  Neurobiol Dis       Date:  2015-11-03       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.